Research brief · Knee tendons

BPC-157, TB-500 and Knee Tendon Problems

People with sore knees search for BPC-157 and TB-500 every day. This page explains what jumper's knee is, what the published research on these two peptides has and has not studied, and how to find suppliers whose lab reports we have checked.

Research use only

  • BPC-157 and TB-500 are sold as research chemicals. They are not for human consumption.
  • Neither has been evaluated or approved by the U.S. FDA or Health Canada for any use in people.
  • This page is general information, not medical advice. If your knee hurts, talk to a licensed clinician such as a doctor or physiotherapist.
The conditions

Two tendons at the front of the knee

01

Jumper's knee

Patellar tendinopathy

Pain at the front of the knee, just below the kneecap, where the patellar tendon joins the kneecap to the shinbone. That tendon carries the pull of the big thigh muscle every time you jump, land, run or squat.

It builds up from repeated jumping and landing: basketball, volleyball, high jump, and sports with sharp changes of direction. The pain is often worst at the start of training, on stairs, when squatting, or after sitting for a long time. It is most common in teenagers and young adults who jump a lot.

02

Quadriceps tendinopathy

The tendon above the kneecap

The same kind of overload problem, but in the quadriceps tendon, which joins the thigh muscle to the top of the kneecap. The pain sits just above the kneecap instead of below it.

It is much less common than jumper’s knee and tends to show up in older athletes.

Not all pain at the front of the knee is a tendon problem. Pain around or behind the kneecap (often called runner’s knee), a sore bump below the knee in growing teens, and problems inside the joint can all feel alike. A clinician can tell them apart with an exam. Researchers now say tendinopathy rather than tendinitis, because an overloaded tendon changes over time rather than staying inflamed.

Related: BPC-157 and elbow tendon problems
What the research has looked at

Animal and lab studies, not knee tendon trials

BPC-157

BPC-157 is a chain of 15 amino acids, first described from a protein found in stomach juice. Much of the published work on it comes from one research group at the University of Zagreb.

We found no published study of BPC-157 in the patellar tendon or in jumper’s knee. The tendon studies were done in rats and in tendon cells grown in a dish, and most used the Achilles tendon at the back of the ankle, not the knee.

  • Staresinic and colleagues, 2003, Journal of Orthopaedic Research (PubMed 14554208): rats with a cut Achilles tendon, plus rat tendon cells in a dish. Researchers compared tendon strength and tissue structure in rats given BPC-157 with rats given none.
  • Krivic and colleagues, 2006, Journal of Orthopaedic Research (PubMed 16583442): rats whose Achilles tendon had been detached from the bone, with the same kind of comparison.
  • Chang and colleagues, 2011, Journal of Applied Physiology (PubMed 21030672): tendon cells taken from rat Achilles tendons and grown in the lab. The study measured how the cells grew, survived and moved.
  • Cerovecki and colleagues, 2010, Journal of Orthopaedic Research (PubMed 20225319): rats whose medial collateral ligament, on the inner side of the knee, had been cut in surgery. This is a ligament, which joins bone to bone, not the patellar tendon.
  • Japjec and colleagues, 2021, Biomedicines (PubMed 34829776): rats in which the quadriceps tendon was cut away from the thigh muscle. It studied the point where muscle meets tendon after a surgical cut, which is a different problem from slow overload in jumper’s knee.
  • Gwyer, Wragg and Wilson, 2019, Cell and Tissue Research (PubMed 30915550): a review of the muscle, tendon and ligament research on BPC-157, which points out that the work so far is almost all in animals.

TB-500

TB-500 is a short lab-made peptide based on one active region of thymosin beta-4, a protein found in most human cells. Most published research is on full thymosin beta-4, not on the TB-500 fragment that suppliers sell.

We found no published study of TB-500 or thymosin beta-4 in the patellar tendon or in jumper’s knee. Cell and animal studies of thymosin beta-4 have looked at how cells move, how new blood vessels form and how skin wounds close, for example Malinda and colleagues, 1999, Journal of Investigative Dermatology (PubMed 10469335), in rats.

  • Xu and colleagues, 2013, Regulatory Peptides (PubMed 23523891): rats with a cut medial collateral ligament, the same knee ligament as the Cerovecki study above, compared with a control group. Again a ligament, not a tendon, and full thymosin beta-4, not TB-500.
  • Biçer and colleagues, 2026, Joint Diseases and Related Surgery (PubMed 42542926): 32 rats with a cut and stitched Achilles tendon, split into four groups: no peptide, BPC-157, TB-500, and both. The authors call their findings preliminary and say longer studies are needed.

Studies in people

  • Lee and Padgett, 2021, Alternative Therapies in Health and Medicine (PubMed 34324435): a look back through the charts of 17 patients at one clinic in Florida who had different kinds of knee pain; 16 were reached for follow-up. It was not a trial. The report describes no comparison group and does not single out jumper’s knee, so it cannot tell whether any change came from the peptide, from time, or from other care.
  • Poolton, Minett and Kazmi, 2026, Acta Orthopaedica Belgica (PubMed 42885452): a systematic review of human studies of BPC-157 in orthopaedics. It found three small studies with 30 people in total, judged all three to be of poor quality, and rated the certainty of the evidence very low. Its authors conclude that BPC-157 should not be used in people outside regulated clinical trials.
  • Vasireddi and colleagues, 2025, HSS Journal (PubMed 40756949): a systematic review that found 36 studies of BPC-157 for muscle, tendon, ligament and bone injuries. 35 were in animals or cells and one was in people. It reports finding no clinical safety data.

What this means for people

Human evidence is limited. We found no published randomized controlled trial of BPC-157 or TB-500 in people with jumper’s knee, quadriceps tendinopathy or any other knee tendon problem.

Results in rats and in cells often do not carry over to people, and a cut tendon in a rat is not the same as a tendon worn down by months of jumping. The studies above do not show that either peptide is harmless or useful for anyone’s knee.

In September 2023 the FDA placed BPC-157 in Category 2 of its bulk substances for compounding, the group that may present significant safety risks. The nominations were later withdrawn, and since April 2026 the FDA lists it as "nominated but withdrawn", while still saying it lacks the information to know whether BPC-157 would cause harm in people.

The World Anti-Doping Agency prohibits BPC-157 and TB-500 at all times. Athletes who are drug tested should know this before going near either one.

Sourcing

How to find lab-tested suppliers

If you buy research peptides for lab work, the lab report is the only thing that tells you what is in the vial. A useful report:

  • Names the exact product and the batch or lot number you are buying, not a batch from last year.
  • Comes from an independent lab, and the lab lets you look the report up on its own website.
  • Shows an identity test (usually mass spectrometry) and a purity test (usually HPLC). Endotoxin and sterility tests add more.
  • Covers a single peptide. A report on a blend says nothing about the same peptide sold on its own.

Every supplier below has at least one BPC-157 or TB-500 lab report on its listing that we matched against the testing lab’s own copy. A checked report means the document is real and matches the product name. It is not an endorsement of the supplier or of any use.

Lab-checked · BPC-157 and TB-500

Suppliers with lab-checked BPC-157 or TB-500 reports

01
Arctic Lab Supply

Arctic Lab Supply

Anchorage, AK, US

BPC-157 · TB-5003 checked reportsPurityLatest test 2026-11-01

Tested by Freedom Diagnostics, ILS Laboratories

02
LabFirst Peptides

LabFirst Peptides

Santa Ana, CA, US

BPC-1574 checked reportsSterility, Purity, EndotoxinLatest test 2026-10-08

Tested by Kovera Labs

03
akeosmicra

akeosmicra

Dallas, TX, US

BPC-1571 checked reportPurityLatest test 2026-09-10

Tested by Kovera

04
Elite Synthetics

Elite Synthetics

Huntington Beach, CA, US

BPC-157 · TB-5006 checked reportsPurityLatest test 2026-09-07

Tested by Bioviridian

05
ReviveLab

ReviveLab

Toronto, ON, CA

BPC-1571 checked reportPurityLatest test 2026-09-01

Tested by Janoshik

06
Luv Aminos

Luv Aminos

Albuquerque, NM, US

BPC-1571 checked reportPurityLatest test 2026-07-15

Tested by Freedom Diagnostics Testing

07
Hydro Research

Hydro Research

Milwaukee, WI, US

BPC-157 · TB-5008 checked reportsPurity, Heavy metals, Sterility, Endotoxin

Tested by Janoshik Analytical

Field notes

Frequently asked questions

01

Is there research on BPC-157 or TB-500 for jumper's knee?

Not that we could find. A PubMed search for either peptide, or for thymosin beta-4, together with the patellar tendon, patellar tendinopathy, jumper’s knee or the quadriceps tendon turned up one rat study, in which the quadriceps tendon was surgically cut away from the muscle. The rest of the tendon research is in rats and cells, mostly using the Achilles tendon. The only report in people with knee pain that we found is a small chart review with no comparison group.

02

What is the difference between jumper's knee and runner's knee?

Jumper’s knee is a problem in the patellar tendon, and the pain sits just below the kneecap. Runner’s knee usually means pain around or behind the kneecap, where it glides over the thighbone, and it is not a tendon problem. A clinician can tell them apart.

03

Are BPC-157 and TB-500 approved for people?

No. Neither is approved by the U.S. FDA or Health Canada for any human use, and both are banned in sport by the World Anti-Doping Agency. They are sold as research chemicals, not for human consumption.

04

What does lab-checked mean on Peptide Alliance?

It means we matched a supplier’s uploaded lab report against the testing lab’s own copy. It confirms the report is genuine and names the product. It does not mean we endorse the product or any use of it.